This inventor holds 1 USPTO granted patent. Top assignee: Fresenius Kabi Oncology Limited. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Ajeet Kumar Singh: Innovator in Pharmaceutical Formulations
Introduction
Ajeet Kumar Singh is a notable inventor based in Sahibabad, Ghaziabad, India. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of stable pharmaceutical compositions. His work is characterized by a focus on improving the stability and efficacy of drug formulations.
Latest Patents
Ajeet Kumar Singh holds a patent for a "Stable oxaliplatin formulation." This innovative patent describes a storage-stable pharmaceutical composition that comprises a solution of Oxaliplatin in water, along with a catalytic amount of a carbohydrate. The process for forming this pharmaceutical composition involves dissolving a known amount of Oxaliplatin in water, adding a carbohydrate in the range of 0.0010% to 0.05% w/v, agitating the mixture to achieve a clear solution, filtering it through a filter membrane under aseptic conditions, and filling the resulting solution into glass vials sealed with elastomeric stoppers and aluminum flip-off seals.
Career Highlights
Ajeet Kumar Singh is currently associated with Fresenius Kabi Oncology Limited, where he applies his expertise in pharmaceutical formulations. His work at the company has contributed to advancements in oncology treatments, enhancing the quality and stability of essential medications.
Collaborations
Throughout his career, Ajeet Kumar Singh has collaborated with several professionals in the field. Notable coworkers include Satish Chandra Upadhyay and Manoj Kumar Pananchukunnath, who have worked alongside him in various projects aimed at improving pharmaceutical formulations.
Conclusion
Ajeet Kumar Singh's contributions to the pharmaceutical industry, particularly through his patent on stable oxaliplatin formulations, highlight his innovative spirit and dedication to improving drug stability. His work continues to impact the field positively, making significant strides in oncology treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
